Probiotics are live microorganisms that, when given in sufficient proportions, provide a health benefit to the host. Lactic acid bacteria and bifidobacteria are the most common microorganisms used as probiotics, however other bacteria and yeasts are also employed. It is critical to emphasise that probiotics have strain-specific biological effects, and that the success or failure of one strain cannot be generalised to another. As a result, effective strain detection using cutting-edge molecular and computer-based methods is critical. 16S rRNA gene sequence analysis and DNA-DNA hybridisation procedures can be used to identify species. Various reproducible genetic approaches or unique phenotypic features can be used to further identify strains. In vitro research is used to gain knowledge of probiotic strains as the first stage.
Title : Overcoming manufacturing challenges in next-generation probiotics: From anaerobic cultivation to clinical-grade formulation
Jason Ryan, Sacco System, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic – results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India
Title : A case-cohort study of the outcomes of probiotics on wound healing in a private hospital in Abu Dhabi
Najat Amharar, Burjeel, United Arab Emirates
Title : Potential for prebiotic food supplement production from by-products of dried persimmon (Diospyros kaki)
Yasin Ozdemir, Ataturk Horticultural Central Research Institute, Turkey